Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers

Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers

US Patent 11401341 · Granted Aug 2, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Recombinant monoclonal antibodies and corresponding antigens for colon and pancr2025
Recombinant monoclonal antibodies and corresponding antigens for colon and pancr2025
Recombinant monoclonal antibodies and corresponding antigens for colon and pancr2025
Recombinant monoclonal antibodies and corresponding antigens for colon and pancr2024
Recombinant monoclonal antibodies and corresponding antigens for colon and pancr2024
Recombinant monoclonal antibodies and corresponding antigens for colon and pancr2023
Colon and pancreas cancer specific antigens and antibodies2022
Recombinant monoclonal antibodies and corresponding antigens for colon and pancr2019
Recombinant monoclonal antibodies and corresponding antigens for colon and pancr2018
Recombinant monoclonal antibodies and corresponding antigens for colon and pancr2018
Recombinant monoclonal antibodies and corresponding antigens for colon and pancr2017
Recombinant monoclonal antibodies and corresponding antigens for colon and pancr2016